Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
October 9, 2025
Respiratory Today—October 9, 2025
October 8, 2025
Latest Immunology News – Sept 25th to Oct 8th 2025
October 8, 2025
Immunology Weekly News – October 8th 2025
October 8, 2025
Neuroscience Weekly News – October 8th 2025
October 7, 2025
ESGCT 2025 Preview: Key Gene & Cell Therapy Highlights to Watch
October 7, 2025
Latest Endocrinology News – Sept 24th to Oct 7th 2025
October 7, 2025
Endocrinology Weekly Update – October 7th 2025
October 7, 2025
Obesity Weekly News – October 7th 2025
October 6, 2025
Latest Artificial Intelligence and Digital Health News – Sept 23rd to Oct 6th 2025
October 6, 2025
Artificial Intelligence and Digital Health Weekly News – October 6th 2025
October 6, 2025
Latest Hematology News – Sept 22nd to Oct 6th 2025
October 6, 2025